Çetin Sinan, Uğur Mediha
Department of Infectious Diseases and Clinical Microbiology, Giresun University School of Medicine, Giresun, Türkiye.
Department of Medical Microbiology, Giresun University School of Medicine, Giresun, Türkiye.
Infect Dis Clin Microbiol. 2024 Dec 19;6(4):268-275. doi: 10.36519/idcm.2024.380. eCollection 2024 Dec.
is one of the leading causes of antibiotic-associated diarrhea. Recurrent infection (rCDI) is significant because of prolonged hospital stays, morbidity, and additional costs. Our study aimed to examine the characteristics of infections and investigate factors associated with recurrence.
Adult patients with signs of acute gastroenteritis and gastrointestinal polymerase chain reaction (GI PCR) panel tests performed on stool material, and was detected as the causative agent were included in the study. rCDI was defined as the recurrence of symptoms and re-detection of in the GI PCR panel within eight weeks after the onset of the initial episode in patients whose symptoms improved with appropriate antimicrobial treatment. Variables in patients with and without recurrence were compared, and risk factors for recurrence were investigated.
A total of 59 patients with infection (CDI) were diagnosed. The median age of patients was 75, and 57.6% were male. Forty-nine patients (83.1%) were diagnosed with the infection while hospitalized. The most commonly used treatment was metronidazole. rCDI was identified in eight patients. The presence of malignancy, hematological malignancy, development of CDI episode in the intensive care unit, and continuation of antibiotic treatment for non- etiology after CDI diagnosis were statistically more common in the recurrence group (<0.05). Mortality during hospitalization occurred in a total of 11 patients (18.6%).
CDI is important because of its frequent occurrence and potential for fatal outcomes. It is crucial to identify patients at risk for recurrence. In our study, the development of CDI attacks in the intensive care unit, malignancy, and continuation of antibiotic treatment for non-CDI infection after CDI diagnosis were found to be associated with recurrence. Evaluating these parameters in patient follow-up will contribute to prognostic assessment.
是抗生素相关性腹泻的主要原因之一。复发性感染(rCDI)因住院时间延长、发病率和额外费用而具有重要意义。我们的研究旨在检查感染的特征并调查与复发相关的因素。
纳入有急性胃肠炎体征且对粪便样本进行了胃肠道聚合酶链反应(GI PCR)检测并检测出为病原体的成年患者。rCDI定义为在初始发作症状经适当抗菌治疗改善后的患者中,初始发作后八周内症状复发且在GI PCR检测中再次检测到。比较有复发和无复发患者的变量,并调查复发的危险因素。
共诊断出59例艰难梭菌感染(CDI)患者。患者的中位年龄为75岁,57.6%为男性。49例患者(83.1%)在住院期间被诊断出感染。最常用的治疗药物是甲硝唑。8例患者被确定为rCDI。复发组中恶性肿瘤、血液系统恶性肿瘤、重症监护病房中CDI发作的发生以及CDI诊断后因非艰难梭菌病因继续使用抗生素治疗在统计学上更为常见(<0.05)。住院期间共有11例患者(18.6%)死亡。
CDI因其频繁发生和潜在的致命后果而很重要。识别有复发风险的患者至关重要。在我们的研究中,发现重症监护病房中CDI发作的发生、恶性肿瘤以及CDI诊断后因非CDI感染继续使用抗生素治疗与复发有关。在患者随访中评估这些参数将有助于预后评估。